New Zealand markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
202.54+3.14 (+1.57%)
At close: 04:00PM EDT
203.48 +0.94 (+0.46%)
After hours: 06:35PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
1,449,700
1,556,100
4,000,600
5,888,500
4,430,700
Depreciation & amortisation
528,200
487,700
457,200
680,600
1,016,600
Deferred income taxes
-410,800
-426,800
149,000
67,100
108,300
Stock-based compensation
236,200
238,600
198,300
182,300
157,500
Change in working capital
-594,800
-145,500
-187,200
199,300
400,200
Accounts receivable
200,100
324,800
2,800
68,800
-205,200
Inventory
-492,500
-462,400
-316,300
-19,200
-52,100
Other working capital
2,772,500
3,345,000
3,678,000
6,409,100
5,301,600
Other non-cash items
616,900
337,100
119,900
5,500
31,100
Net cash provided by operating activities
3,032,700
3,639,900
4,229,800
7,078,600
6,187,700
Cash flows from investing activities
Investments in property, plant and equipment
-260,200
-294,900
-551,800
-669,500
-886,100
Acquisitions, net
-
0
-565,500
-1,044,400
-2,176,600
Purchases of investments
-4,028,900
-3,808,700
-6,838,700
-5,252,600
-8,157,700
Sales/maturities of investments
3,132,100
3,498,900
7,374,300
6,486,300
9,173,700
Other investing activities
10,000
12,900
-26,900
27,000
400
Net cash used for investing activities
-1,147,000
-563,700
-608,600
470,500
-2,046,300
Cash flows from financing activities
Debt repayment
-700
-170,000
-1,500,000
0
-3,200
Common stock repurchased
-1,200,000
-1,800,000
-6,679,100
-5,868,300
-4,352,600
Other financing activities
-122,600
-115,500
-56,400
7,900
-114,100
Net cash used provided by (used for) financing activities
-1,317,700
-2,086,200
-5,272,700
-5,860,400
-4,472,000
Net change in cash
568,000
990,000
-1,651,500
1,688,700
-330,600
Cash at beginning of period
1,217,500
1,331,200
2,913,700
1,224,600
1,573,800
Cash at end of period
1,785,500
2,261,400
1,331,200
2,913,700
1,224,600
Free cash flow
Operating cash flow
3,032,700
3,639,900
4,229,800
7,078,600
6,187,700
Capital expenditure
-260,200
-294,900
-551,800
-669,500
-886,100
Free cash flow
2,772,500
3,345,000
3,678,000
6,409,100
5,301,600